ARTICLE | Regulation
New NASDAQ listings see mixed performance
Erasca, Imago posted single-digit gains, while TScan shed nearly a third of its value
July 17, 2021 2:21 AM UTC
Three newly public biotechs raised more than $500 million since Thursday’s market close, and saw varied first-day performance ranging from single-digit gains to double-digit losses.
After a brief slowdown in 2Q21, IPOs began to pick up again in June, and the pace of new listings is unlikely to slow given that insiders continue to drive the deals. ...